Last updated: 2026-09-16 10:31:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Hims & Hers Health, Inc. (HIMS) operates in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE sector and is listed on NYSE. The stock is currently priced at $28,07, with a market capitalisation of $6,72B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13,74 to $65,30. This page covers its latest market performance, valuation, price trends and company information.
$6,72B | |
$27,96 | |
$72,98 | |
$2,72 | |
$27,85 | |
30,11K | |
14,01M | |
-- | |
$65,30 | |
$13,74 | |
-- | |
-- |
Hims & Hers Health, Inc. (HIMS) is trading at $28,07 in pre-market trading as of 2026-09-16 10:29:00, up 0,77% ($0,21) from the previous close of $27,85
Pre-market trading shows how investors are pricing HIMS before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Hims & Hers Health, Inc. (HIMS) moved from $27,71 to $28,07, representing a gain of 1,28% ($0,36).
The stock traded between $26,73 and $29,44 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 8,43 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 27,8%
HIMS is currently trading at $28,07, placing it 27,8% of the way from its 52-week low of $13,74 to its 52-week high of $65,30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Employees | 2442 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Hims & Hers Health, Inc. (HIMS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.